• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAlkermes
    Picture of Alkermes logo

    ALKSV — Alkermes News Story

    $22.640.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeLarge CapNeutral
    • Market Cap
      $4.05bn
    • Enterprise Value
      $3.45bn
    • Revenue
      $1.11bn
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ALKSV Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ALKSV Dividends
    All News

    Brief: Alkermes Q1 revenue USD 287.6 million

    Picture of Alkermes logoAlkermes
    26/04/2023 12:43
    Apr 26 (Reuters) - Alkermes Q1 revenue USD 287.6 million
    

    Recent news on Alkermes

    See all news
    • Brief: Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study Of Alixorexton In Adults With Narcolepsy Type 2 At Sleep 2026

      17/06/2026 21:15
    • Brief: Alkermes Announces Positive Topline Results From Revitalyz Phase 3 Study Evaluating Lumryz

      12/05/2026 12:02
    • Brief: Alkermes Announces Effectiveness Of Mural Oncology Form 10 Registration Statement

      31/10/2023 22:01
    • Alkermes Plc reports results for the quarter ended in September - Earnings Summary

      25/10/2023 14:32
    • Brief: Alkermes Q3 Net Income USD 47.8 Million

      25/10/2023 12:00

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.